Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2001-10-11
pubmed:abstractText
Dietary intake of soy has been linked with decreased cancer risk, and the active compounds in soy that have been identified include the isoflavones genistein and daidzein. Since these compounds have antioxidant properties, we examined levels of oxidative damage in blood of six women and six men before and during soy supplementation using Novasoy tablets. Blood samples were obtained at weekly intervals for 3 weeks from the women taking 50-mg isoflavones once daily and the men taking 50-mg isoflavones twice daily. Plasma levels of genistein and daidzein increased after supplementation with maximal levels occurring at 2 weeks for the women while levels in men kept increasing over the 3 weeks of study. There was wide variation between individuals in the levels of isoflavones achieved. Mean levels of 5-hydroxymethyl-2'-deoxyuridine (5-OHmdU) in DNA from nucleated blood cells decreased after 1 week of supplementation in the women, with a decrease of 47% in mean 5-OHmdU levels after 3 weeks. In men, mean 5-OHmdU levels did not decrease until after 3 weeks of supplementation, at which there was 61% decrease. Mean plasma levels of 8-isoprostanes were not changed appreciably in either men or women. These pilot results suggest that soy isoflavone supplementation decreases levels of oxidative DNA damage in humans, and this may be a mechanism behind the cancer-preventive effects of soy isoflavones.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0304-3835
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
172
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-6
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11595123-Adult, pubmed-meshheading:11595123-Antineoplastic Agents, pubmed-meshheading:11595123-Chromatography, High Pressure Liquid, pubmed-meshheading:11595123-DNA Damage, pubmed-meshheading:11595123-Dietary Supplements, pubmed-meshheading:11595123-Dinoprost, pubmed-meshheading:11595123-Estrogens, Non-Steroidal, pubmed-meshheading:11595123-F2-Isoprostanes, pubmed-meshheading:11595123-Female, pubmed-meshheading:11595123-Genistein, pubmed-meshheading:11595123-Humans, pubmed-meshheading:11595123-Immunoenzyme Techniques, pubmed-meshheading:11595123-Isoflavones, pubmed-meshheading:11595123-Male, pubmed-meshheading:11595123-Middle Aged, pubmed-meshheading:11595123-Oxidative Stress, pubmed-meshheading:11595123-Phytotherapy, pubmed-meshheading:11595123-Plant Extracts, pubmed-meshheading:11595123-Sex Factors, pubmed-meshheading:11595123-Soybeans, pubmed-meshheading:11595123-Thymidine, pubmed-meshheading:11595123-Time Factors
pubmed:year
2001
pubmed:articleTitle
Effect of soy isoflavone supplementation on markers of oxidative stress in men and women.
pubmed:affiliation
Barbara Ann Karmanos Cancer Institute, 110 East Warren, Detroit, MI 48201, USA. djuricz@karmanos.org
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.